Abstract
The anticancer and anti-inflammatory effects of carboxyamidotriazole (CAI) have been demonstrated in several studies, but the underlying mechanisms remain to be elucidated. This study showed that CAI caused metabolic reprogramming of pancreatic cancer cells. The inhibition of mitochondrial oxidative metabolism by CAI led to increased glutamine-dependent reductive carboxylation and enhanced glycolytic metabolism. The presence of environmental substances that affect cellular metabolism, such as glutamine and pyruvate, attenuated the anticancer efficacy of CAI. Based on the action of CAI: 1) when glutamine was removed, the NAD+/NADH ratio was decreased, the synthesis of cellular aspartate was reduced, and autophagy flux was blocked; and 2) when glycolysis was pharmacologically inhibited, the ATP level was significantly decreased, the cell viability was greatly inhibited, and the compensatory rescue effect of glutamine was eliminated. When combined with chemotherapy, cotreatment with CAI and the glycolysis inhibitor 2-deoxyglucose (2-DG) inhibited the pancreatic cancer progression after chemotherapy. As the inhibition of mitochondrial oxidative metabolism can explain several anticancer activities of CAI reported previously, includi...Continue Reading
References
Jan 15, 1972·International Journal of Cancer. Journal International Du Cancer·S C BansalH O Sjögren
Oct 9, 1996·International Journal of Cancer. Journal International Du Cancer·W J WasilenkoP F Schellhammer
Jan 1, 1996·Investigational New Drugs·D S Shewach, T S Lawrence
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Oct 1, 2003·Angiogenesis·K J LuzziA C Groom
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LouvetUNKNOWN GISCAD
Nov 25, 2005·Journal of Cell Science·Olivier MignenThierry Capiod
Aug 2, 2007·Expert Opinion on Therapeutic Targets·Hanne HaglandKarl J Tronstad
Mar 11, 2010·Cancer Research·Issam Ben SahraFrédéric Bost
Jun 19, 2010·Autophagy·Issam Ben SahraFrédéric Bost
Nov 3, 2010·Cancer Letters·Chiara CorradoRiccardo Alessandro
Oct 14, 2011·Molecular Cancer Therapeutics·Jae-Ho CheongGordon B Mills
Nov 22, 2011·Nature·Andrew R MullenRalph J DeBerardinis
Mar 24, 2012·Cancer Cell·Patrick S Ward, Craig B Thompson
Aug 15, 2014·Nature·Andrea VialeGiulio F Draetta
Sep 23, 2014·Nature Cell Biology·Valerie S LeBleuRaghu Kalluri
Dec 18, 2014·Nature Chemical Biology·Samuel E Weinberg, Navdeep S Chandel
Jul 1, 2015·Proceedings of the National Academy of Sciences of the United States of America·M Cecilia CainoDario C Altieri
Aug 2, 2015·Cell·Kıvanç BirsoyDavid M Sabatini
Aug 2, 2015·Cell·Lucas B SullivanMatthew G Vander Heiden
Aug 25, 2015·Cell Metabolism·Francesc BaixauliMaria Mittelbrunn
Sep 15, 2015·Cell Metabolism·Patricia SanchoChristopher Heeschen
Sep 17, 2015·Cancer Research·Andrea VialeGiulio F Draetta
Nov 3, 2015·Cancer Letters·Rui JuDechang Zhang
Jan 16, 2016·Cell Metabolism·Natalya N Pavlova, Craig B Thompson
Oct 18, 2016·Cell Metabolism·Dan Y GuiMatthew G Vander Heiden
Dec 3, 2016·Proceedings of the National Academy of Sciences of the United States of America·Jianhai DuJennifer R Chao
May 16, 2017·Nature Cell Biology·Elena AnsóNavdeep S Chandel
May 19, 2017·The Journal of Pharmacology and Experimental Therapeutics·Chen ChenLei Guo
Jan 13, 2018·Nature·Véronique FrattiniAntonio Iavarone